Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a clinical research partnership and the formation of a Clinical Research Center of Excellence in the Detroit metropolitan area.
The Center of Excellence will initially reside in Bloomfield Hills near the Detroit metro area, focusing on clinical trials and medical innovation in cardiology. This partnership will provide Profound with access to CAVA’s extensive network of physicians, while CAVA will benefit from Profound’s expertise in patient recruitment, trial execution, and data management.
This collaboration aligns seamlessly with Profound's mission of bringing patients access to tomorrow's treatments today. By leveraging the combined strengths of both organizations, patients will have the opportunity to participate in cutting-edge clinical trials, gaining early access to innovative therapies that can significantly improve their health outcomes.
Direct benefits for patients include the introduction of innovative therapies to the Detroit community, advancing the development of new treatments and cures, and more. By working together, Profound and CAVA are committed to providing patients with opportunities to participate in clinical trials that can improve their treatments and overall health outcomes. This partnership is a testament to Profound's core values of compassion, efficiency, progress, and integrity, ensuring that patients receive the best possible care through advanced medical research and innovation.
Patient Benefits:
- Access to Cutting-Edge Therapies and Treatments: Patients will have early access to the latest advancements in cardiology care, reducing wait times for new therapies and providing hope for those with limited options.
- Participation in Advanced Clinical Trials: Opportunities to be part of research that can lead to breakthrough treatments and personalized therapy plans based on the latest clinical data.
- Improved Health Outcomes: Through innovative care options that target specific cardiology-related issues, ensuring a more holistic approach to patient health.
- Enhanced Support: From a network of leading cardiologists and researchers dedicated to comprehensive patient care and coordinated management.
- Convenient Access: To state-of-the-art medical facilities in their community, minimizing travel burdens and associated stress.
- Collaboration with Your Own Cardiologist: Patients can participate in clinical trials while continuing care with their trusted cardiologist, ensuring continuity and personalized treatment.
Profound Research and CAVA are currently partnering on cardiology trials with more launching in the coming months.
About Profound Research
Profound Research is an integrated clinical research network composed of trial sites embedded into independent physician practices. Profound’s mission is to expand access to clinical research for patients in the community and give community physicians more therapeutic options. Profound Research has locations across Southern California and in the Detroit metropolitan area and is expanding nationwide. The company has a team of experienced and dedicated research professionals who are committed to providing the highest quality clinical research support to physicians and their patients.
About Cardiology and Vascular Associates
Cardiology and Vascular Associates (CAVA), established in 2000, is one of Michigan’s premier cardiology practices. With 11 board-certified cardiologists and 8 mid-level providers, CAVA offers comprehensive cardiac and vascular care across 5 office locations and multiple area hospitals. Our diagnostic centers, accredited by the IAC, feature advanced equipment and certified technicians. CAVA's services include diagnostic and interventional cardiology, cardiac consultation, arrhythmia management, and endovascular procedures. Our physicians, trained at top institutions worldwide, hold leadership roles in prestigious hospitals and actively participate in cutting-edge research.
